May 5, 2026 04:05PM
Apr 20, 2026 05:00PM
Apr 20, 2026 05:00PM
Feb 24, 2026 04:05PM
Feb 17, 2026 08:30AM
Feb 9, 2026 11:15AM
Feb 9, 2026 11:14AM Lunai Bioworks, Inc. Issues Letter to Shareholders
Dec 22, 2025 07:06AM
Dec 9, 2025 07:00AM
Oct 24, 2025 08:29AM
Sep 17, 2025 04:30PM
Sep 17, 2025 04:30PM
Jul 31, 2025 08:44AM
Jul 31, 2025 08:44AM Supernus Pharmaceuticals Completes Acquisition of Sage Therapeutics
Jun 17, 2025 06:42AM
Jun 16, 2025 07:01AM
Jun 16, 2025 07:00AM
May 29, 2025 08:30AM
May 28, 2025 04:05PM
May 20, 2025 08:30AM
Feb 25, 2025 04:01PM Supernus Announces Fourth Quarter and Full Year 2024 Financial Results
Feb 4, 2025 11:28AM
Feb 4, 2025 11:19AM
Feb 4, 2025 09:02AM
Feb 4, 2025 09:00AM
Jan 27, 2025 08:00AM
Jan 27, 2025 08:00AM
Jan 27, 2025 08:00AM Supernus Announces Label Update for Non-Stimulant ADHD Treatment, Qelbree®, Including New Pharmacodynamic Data and Information for Breastfeeding Women
Nov 4, 2024 04:05PM
Sep 24, 2024 07:30AM
Aug 19, 2024 07:01AM
Aug 19, 2024 07:00AM
Aug 1, 2024 04:30PM
May 23, 2024 04:06PM
May 23, 2024 04:05PM Supernus Announces Promising Interim Data from Ongoing Open-Label Phase 2a Study of SPN-817 in Epilepsy
May 8, 2024 04:05PM
May 7, 2024 10:01AM
May 7, 2024 10:00AM
Apr 8, 2024 10:10AM
Apr 8, 2024 10:09AM
Apr 8, 2024 08:05AM
Apr 8, 2024 08:00AM Supernus Provides Regulatory Update for SPN-830
Feb 27, 2024 04:05PM
Feb 5, 2024 08:31AM
Feb 5, 2024 08:30AM
Nov 8, 2023 04:05PM
Nov 2, 2023 07:06AM
Nov 2, 2023 07:00AM
Oct 16, 2023 05:34PM Jay Glazer Teams Up with Supernus Pharmaceuticals to Raise Awareness of ADHD and his Qelbree® Journey
Oct 9, 2023 04:45PM

322,084 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All